{{item.videoDuration}}
{{item.title}}
{{item.text}}
{{item.videoDuration}}
{{item.title}}
{{item.text}}
PwC’s Corporate Finance team is pleased to announce the sale of REHOLD AG and its operating subsidiary Gebr. Renggli AG (“Gebr. Renggli”) to TT Medic GmbH (“TT Medic”). PwC supported the shareholders of Gebr. Renggli as lead financial advisor on the transaction.
Founded in 1974 by three brothers, Gebr. Renggli is a leading supplier of thermoplastic products for the medical sector. In its state-of-the-art ISO 7 clean room facilities in Schaffhausen, the company develops and manufactures complex injection molded parts and assemblies for applications in emergency medicine, ophthalmology, dentistry and other markets.
In order to secure the long-term growth of the company, the representatives of the second generation of the founding families decided to enter into a partnership with Hubertus Goller GmbH ("Goller Systems"), an Austria-based system solution provider for medical and pharmaceutical applications and a subsidiary of TT Medic. TT Medic is owned by entrepreneurial families Christoph Swarovski and Gaudenz Trapp. In the course of the transaction, which will give Gebr. Renggli better access to the European market, the owners of Gebr. Renggli will transfer their shares to TT Medic.
The transaction is scheduled to be completed at the end of February 2022.
The PwC team
Corporate Finance / M&A:
- Sascha Beer
- Michael Huber
- Alessandro Rossi
- David Veljkovic
